A Aforeworn
Forewarned is forearmed.
Home › Niches › Cosmetics & Personal-Care (MoCRA) › Change
Low urgency

Latex-containing Devices; User Labeling

Detected July 6, 2026 · in Cosmetics & Personal-Care (MoCRA)

FDA proposes labeling requirements for medical devices containing natural rubber latex that contact human tissue. While this rule targets medical devices, cosmetics and personal care products using latex in packaging or applicators may be indirectly affected if they are classified as medical devices or if FDA extends similar logic to cosmetics under MoCRA.

Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Indie beauty brands, contract manufacturers, private-label makers, importers/distributors that produce or distribute cosmetics or personal care products containing natural rubber latex in components that contact skin (e.g., applicators, packaging). should confirm how it applies to their specific situation before acting. There is a time constraint attached: No current deadline for cosmetics. If your product is a medical device, comment period on proposed rule ended in 1996.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

FDA proposes to require labeling on medical devices containing natural rubber latex that may contact human tissue. This is a proposed rule from 1996, not yet final, and applies to medical devices, not cosmetics. However, it signals potential future labeling expectations for latex in consumer products.

Who it affects

Indie beauty brands, contract manufacturers, private-label makers, importers/distributors that produce or distribute cosmetics or personal care products containing natural rubber latex in components that contact skin (e.g., applicators, packaging).

What you must do

Monitor for any FDA guidance extending latex labeling to cosmetics under MoCRA. Currently no immediate action needed for cosmetics unless your product is also a medical device.

Deadline

No current deadline for cosmetics. If your product is a medical device, comment period on proposed rule ended in 1996.

Source: https://www.federalregister.gov/documents/1996/06/24/96-15990/latex-containing-devices-user-labeling

Never miss a change like this again

Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Cosmetics & Personal-Care (MoCRA)